197 related articles for article (PubMed ID: 23638631)
21. Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
De Leo V; Fruzzetti F; Musacchio MC; Scolaro V; Di Sabatino A; Morgante G
Contraception; 2013 Sep; 88(3):364-8. PubMed ID: 23769016
[TBL] [Abstract][Full Text] [Related]
22. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Davis SR; Bitzer J; Giraldi A; Palacios S; Parke S; Serrani M; Mellinger U; Nappi RE
J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
[TBL] [Abstract][Full Text] [Related]
23. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Klipping C; Duijkers I; Parke S; Mellinger U; Serrani M; Junge W
Drugs R D; 2011; 11(2):159-70. PubMed ID: 21679006
[TBL] [Abstract][Full Text] [Related]
24. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
25. Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Tantbirojn P; Taneepanichskul S
Contraception; 2002 Dec; 66(6):401-5. PubMed ID: 12499031
[TBL] [Abstract][Full Text] [Related]
26. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
[TBL] [Abstract][Full Text] [Related]
27. Estradiol valerate/dienogest: a novel oral contraceptive.
Whalen KL; Rose R
Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
[TBL] [Abstract][Full Text] [Related]
28. Effect of dienogest-containing oral contraceptives on lipid metabolism.
Wiegratz I; Lee JH; Kutschera E; Bauer HH; von Hayn C; Moore C; Mellinger U; Winkler UH; Gross W; Kuhl H
Contraception; 2002 Mar; 65(3):223-9. PubMed ID: 11929644
[TBL] [Abstract][Full Text] [Related]
29. Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Palombo-Kinne E; Kuhl H
Contraception; 2011 Aug; 84(2):133-43. PubMed ID: 21757054
[TBL] [Abstract][Full Text] [Related]
30. The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval.
Graziottin A
Eur J Contracept Reprod Health Care; 2016; 21(2):93-105. PubMed ID: 26291185
[TBL] [Abstract][Full Text] [Related]
31. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
Caruso S; Agnello C; Romano M; Cianci S; Lo Presti L; Malandrino C; Cianci A
J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
[TBL] [Abstract][Full Text] [Related]
32. Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.
Golbs S; Domhardt R; Radowicky S; Kałuzny Z; Wisser KH; Zimmermann T
Methods Find Exp Clin Pharmacol; 2002 Nov; 24(9):585-92. PubMed ID: 12616705
[TBL] [Abstract][Full Text] [Related]
33. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.
Jensen JT
Expert Opin Pharmacother; 2010 May; 11(7):1147-57. PubMed ID: 20367275
[TBL] [Abstract][Full Text] [Related]
35. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial.
Yu Q; Zhou Y; Suturina L; Jaisamrarn U; Lu D; Parke S
J Womens Health (Larchmt); 2018 Oct; 27(10):1225-1232. PubMed ID: 29957101
[TBL] [Abstract][Full Text] [Related]
37. Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Burkman RT; Fisher AC; LaGuardia KD
J Reprod Med; 2007 Nov; 52(11):1030-4. PubMed ID: 18161401
[TBL] [Abstract][Full Text] [Related]
38. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
Hampton RM; Zhang HF; Barnowski C; Wan GJ
Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
[TBL] [Abstract][Full Text] [Related]
39. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
40. Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis.
Haverinen A; Luiro K; Kangasniemi MH; Piltonen TT; Hustad S; Heikinheimo O; Tapanainen JS
J Clin Endocrinol Metab; 2022 Jun; 107(7):e3008-e3017. PubMed ID: 35279718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
